HEADER TRANSFERASE 06-FEB-17 5N21 TITLE CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH PYRAZOLO- TITLE 2 PYRIMIDINE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-CELL LYMPHOMA 6 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BCL-6,B-CELL LYMPHOMA 5 PROTEIN,BCL-5,PROTEIN LAZ-3,ZINC COMPND 5 FINGER AND BTB DOMAIN-CONTAINING PROTEIN 27,ZINC FINGER PROTEIN 51; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL6, BCL5, LAZ3, ZBTB27, ZNF51; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.ROBB,A.FERGUSON,D.HARGREAVES REVDAT 2 07-JUN-17 5N21 1 JRNL REVDAT 1 17-MAY-17 5N21 0 JRNL AUTH W.MCCOULL,R.D.ABRAMS,E.ANDERSON,K.BLADES,P.BARTON,M.BOX, JRNL AUTH 2 J.BURGESS,K.BYTH,Q.CAO,C.CHUAQUI,R.J.CARBAJO,T.CHEUNG, JRNL AUTH 3 E.CODE,A.D.FERGUSON,S.FILLERY,N.O.FULLER,E.GANGL,N.GAO, JRNL AUTH 4 M.GRIST,D.HARGREAVES,M.R.HOWARD,J.HU,P.D.KEMMITT,J.E.NELSON, JRNL AUTH 5 N.O'CONNELL,D.B.PRINCE,P.RAUBO,P.B.RAWLINS,G.R.ROBB,J.SHI, JRNL AUTH 6 M.J.WARING,D.WHITTAKER,M.WYLOT,X.ZHU JRNL TITL DISCOVERY OF PYRAZOLO[1,5-A]PYRIMIDINE B-CELL LYMPHOMA 6 JRNL TITL 2 (BCL6) BINDERS AND OPTIMIZATION TO HIGH AFFINITY MACROCYCLIC JRNL TITL 3 INHIBITORS. JRNL REF J. MED. CHEM. V. 60 4386 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28485934 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00359 REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 29307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT : 1411 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2504 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1980 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2374 REMARK 3 BIN R VALUE (WORKING SET) : 0.1967 REMARK 3 BIN FREE R VALUE : 0.2228 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.19 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 130 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1970 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 222 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.89 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.04370 REMARK 3 B22 (A**2) : -3.93550 REMARK 3 B33 (A**2) : 1.89190 REMARK 3 B12 (A**2) : 1.47350 REMARK 3 B13 (A**2) : 0.14910 REMARK 3 B23 (A**2) : -0.67010 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.169 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.089 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.086 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.088 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.085 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2092 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2836 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 782 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 358 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2092 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 275 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 5 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2710 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.25 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.23 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 0.5165 1.4970 -1.5613 REMARK 3 T TENSOR REMARK 3 T11: -0.0414 T22: -0.0384 REMARK 3 T33: -0.0172 T12: 0.0205 REMARK 3 T13: 0.0097 T23: -0.0113 REMARK 3 L TENSOR REMARK 3 L11: 0.3245 L22: 0.2875 REMARK 3 L33: 1.0470 L12: -0.1294 REMARK 3 L13: 0.0111 L23: -0.0842 REMARK 3 S TENSOR REMARK 3 S11: -0.0203 S12: -0.1145 S13: 0.0213 REMARK 3 S21: 0.0595 S22: 0.0105 S23: -0.0216 REMARK 3 S31: -0.0869 S32: -0.1044 S33: 0.0098 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 12.3220 1.4643 -21.1196 REMARK 3 T TENSOR REMARK 3 T11: -0.0449 T22: -0.0466 REMARK 3 T33: -0.0148 T12: -0.0145 REMARK 3 T13: 0.0109 T23: -0.0053 REMARK 3 L TENSOR REMARK 3 L11: 0.4593 L22: 0.4341 REMARK 3 L33: 0.9126 L12: 0.1599 REMARK 3 L13: -0.0049 L23: 0.0296 REMARK 3 S TENSOR REMARK 3 S11: -0.0439 S12: 0.1077 S13: 0.0370 REMARK 3 S21: -0.0655 S22: 0.0226 S23: 0.0128 REMARK 3 S31: -0.0672 S32: 0.0873 S33: 0.0212 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5N21 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29482 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 35.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.34300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: UNKNOWN, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 -115.71 55.60 REMARK 500 GLN A 113 67.52 62.41 REMARK 500 SER B 39 -117.05 59.49 REMARK 500 GLN B 113 68.62 61.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 407 DISTANCE = 6.57 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8HN A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8HN B 202 DBREF 5N21 A 7 128 UNP P41182 BCL6_HUMAN 7 128 DBREF 5N21 B 7 128 UNP P41182 BCL6_HUMAN 7 128 SEQADV 5N21 GLN A 8 UNP P41182 CYS 8 CONFLICT SEQADV 5N21 ARG A 67 UNP P41182 CYS 67 CONFLICT SEQADV 5N21 ASN A 84 UNP P41182 CYS 84 CONFLICT SEQADV 5N21 GLN B 8 UNP P41182 CYS 8 CONFLICT SEQADV 5N21 ARG B 67 UNP P41182 CYS 67 CONFLICT SEQADV 5N21 ASN B 84 UNP P41182 CYS 84 CONFLICT SEQRES 1 A 122 SER GLN ILE GLN PHE THR ARG HIS ALA SER ASP VAL LEU SEQRES 2 A 122 LEU ASN LEU ASN ARG LEU ARG SER ARG ASP ILE LEU THR SEQRES 3 A 122 ASP VAL VAL ILE VAL VAL SER ARG GLU GLN PHE ARG ALA SEQRES 4 A 122 HIS LYS THR VAL LEU MET ALA CYS SER GLY LEU PHE TYR SEQRES 5 A 122 SER ILE PHE THR ASP GLN LEU LYS ARG ASN LEU SER VAL SEQRES 6 A 122 ILE ASN LEU ASP PRO GLU ILE ASN PRO GLU GLY PHE ASN SEQRES 7 A 122 ILE LEU LEU ASP PHE MET TYR THR SER ARG LEU ASN LEU SEQRES 8 A 122 ARG GLU GLY ASN ILE MET ALA VAL MET ALA THR ALA MET SEQRES 9 A 122 TYR LEU GLN MET GLU HIS VAL VAL ASP THR CYS ARG LYS SEQRES 10 A 122 PHE ILE LYS ALA SER SEQRES 1 B 122 SER GLN ILE GLN PHE THR ARG HIS ALA SER ASP VAL LEU SEQRES 2 B 122 LEU ASN LEU ASN ARG LEU ARG SER ARG ASP ILE LEU THR SEQRES 3 B 122 ASP VAL VAL ILE VAL VAL SER ARG GLU GLN PHE ARG ALA SEQRES 4 B 122 HIS LYS THR VAL LEU MET ALA CYS SER GLY LEU PHE TYR SEQRES 5 B 122 SER ILE PHE THR ASP GLN LEU LYS ARG ASN LEU SER VAL SEQRES 6 B 122 ILE ASN LEU ASP PRO GLU ILE ASN PRO GLU GLY PHE ASN SEQRES 7 B 122 ILE LEU LEU ASP PHE MET TYR THR SER ARG LEU ASN LEU SEQRES 8 B 122 ARG GLU GLY ASN ILE MET ALA VAL MET ALA THR ALA MET SEQRES 9 B 122 TYR LEU GLN MET GLU HIS VAL VAL ASP THR CYS ARG LYS SEQRES 10 B 122 PHE ILE LYS ALA SER HET CL A 201 1 HET 8HN A 202 32 HET CL B 201 1 HET 8HN B 202 32 HETNAM CL CHLORIDE ION HETNAM 8HN 2-[(2~{S})-1-[3-CYANO-7-[(2-OXIDANYLIDENE-3,4-DIHYDRO- HETNAM 2 8HN 1~{H}-QUINOLIN-6-YL)AMINO]PYRAZOLO[1,5-A]PYRIMIDIN-5- HETNAM 3 8HN YL]PYRROLIDIN-2-YL]ETHANOIC ACID FORMUL 3 CL 2(CL 1-) FORMUL 4 8HN 2(C22 H21 N7 O3) FORMUL 7 HOH *222(H2 O) HELIX 1 AA1 ARG A 13 ARG A 28 1 16 HELIX 2 AA2 HIS A 46 SER A 54 1 9 HELIX 3 AA3 SER A 54 THR A 62 1 9 HELIX 4 AA4 ASN A 79 SER A 93 1 15 HELIX 5 AA5 ASN A 101 GLN A 113 1 13 HELIX 6 AA6 MET A 114 SER A 128 1 15 HELIX 7 AA7 ARG B 13 ARG B 28 1 16 HELIX 8 AA8 HIS B 46 SER B 54 1 9 HELIX 9 AA9 SER B 54 THR B 62 1 9 HELIX 10 AB1 ASN B 79 SER B 93 1 15 HELIX 11 AB2 ASN B 101 GLN B 113 1 13 HELIX 12 AB3 MET B 114 SER B 128 1 15 SHEET 1 AA1 2 ILE A 9 GLN A 10 0 SHEET 2 AA1 2 ARG B 94 LEU B 95 -1 O LEU B 95 N ILE A 9 SHEET 1 AA2 3 GLU A 41 ALA A 45 0 SHEET 2 AA2 3 VAL A 34 VAL A 38 -1 N ILE A 36 O PHE A 43 SHEET 3 AA2 3 VAL A 71 ASN A 73 1 O ILE A 72 N VAL A 37 SHEET 1 AA3 2 ARG A 94 LEU A 95 0 SHEET 2 AA3 2 ILE B 9 GLN B 10 -1 O ILE B 9 N LEU A 95 SHEET 1 AA4 3 GLU B 41 ALA B 45 0 SHEET 2 AA4 3 VAL B 34 VAL B 38 -1 N ILE B 36 O PHE B 43 SHEET 3 AA4 3 VAL B 71 ASN B 73 1 O ILE B 72 N VAL B 37 SITE 1 AC1 4 MET A 114 HIS A 116 VAL A 117 HOH A 319 SITE 1 AC2 21 MET A 51 ALA A 52 CYS A 53 GLY A 55 SITE 2 AC2 21 TYR A 58 GLU A 81 ASN A 84 ASN A 96 SITE 3 AC2 21 ARG A 98 GLN A 113 MET A 114 GLU A 115 SITE 4 AC2 21 HOH A 312 HOH A 330 HOH A 343 HOH A 357 SITE 5 AC2 21 HOH A 377 ASN B 21 ARG B 24 LEU B 25 SITE 6 AC2 21 ARG B 28 SITE 1 AC3 4 MET B 114 HIS B 116 VAL B 117 HOH B 323 SITE 1 AC4 20 ASN A 21 ARG A 24 LEU A 25 ARG A 28 SITE 2 AC4 20 MET B 51 ALA B 52 CYS B 53 GLY B 55 SITE 3 AC4 20 TYR B 58 GLU B 81 ASN B 84 ASN B 96 SITE 4 AC4 20 ARG B 98 GLN B 113 GLU B 115 HOH B 315 SITE 5 AC4 20 HOH B 316 HOH B 338 HOH B 345 HOH B 365 CRYST1 30.400 38.970 54.930 83.36 75.39 67.21 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.032895 -0.013821 -0.008299 0.00000 SCALE2 0.000000 0.027834 -0.000559 0.00000 SCALE3 0.000000 0.000000 0.018817 0.00000